Furthermore, we also found that plasma SP-D levels in sepsis patients with AKI positively correlated with urinary NGAL levels, suggesting that combined use of SP-D polymorphisms and plasma biomarkers would increase diagnostic and prognostic efficacy for sepsis-induced AKI. The gene discussed is LCN2; the disease is Sepsis.